本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Regenxbio Inc

8.53
-0.0300-0.35%
盤後8.47-0.0600-0.70%19:30 EDT
成交量:102.91萬
成交額:879.75萬
市值:5.63億
市盈率:-2.27
高:8.82
開:8.69
低:8.39
收:8.56
52周最高:16.19
52周最低:5.46
股本:6,601.32萬
流通股本:5,734.27萬
量比:0.94
換手率:1.79%
股息:- -
股息率:- -
每股收益(TTM):-3.7652
每股收益(LYR):-3.7593
淨資產收益率:-137.63%
總資產收益率:-21.20%
市淨率:7.85
市盈率(LYR):-2.27

資料載入中...

2021/06/07

重要事件披露

8-K - Current report
2021/05/05

重要事件披露

8-K - Current report
2021/05/05

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/03/01

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/01

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/01

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/26

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/15

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/08

重要事件披露

8-K - Current report
2021/01/05

重要事件披露

8-K - Current report
2020/12/22

重要事件披露

8-K - Current report
2020/11/04

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/04

重要事件披露

8-K - Current report
2020/10/27

重要事件披露

8-K - Current report